Skip to main content
Caplight Logo









Kamleon

Kamleon

Private
BarcelonaHealthcare & Life Scienceshttps://www.kamleon.com/en/

Last Round

Grant

Aug 20, 2025

Total Funding Raised

$1.09M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kamleon is a health-tech company that provides smart urinalysis solutions for real-time hydration monitoring in fitness, sports, and public facilities.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Sports & Fitness, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

smart urinalhydration monitoringhealth IoTnon-invasive monitoringsmart toiletwearable techathlete performancewellness analyticsremote patient monitoringRPMdigital healthbiometric monitoringfacility managementhealth techquantified self

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kamleon Comparables

Compare Kamleon with similar companies based on industry and business-model similarity.

Kamleon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Intake Health
86%
Olive Diagnostics
72%
Medipee GmbH
69%

Kamleon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 20, 2025
GrantAug 20, 2025
GrantJul 27, 2025
GrantJul 26, 2025
Pre SeedNov 8, 2023

Key People

Founding team and executive leadership

Jordi Ferré Albiol

Co-Founder and CEO

Founding Team

Kamleon Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 32% MoM, reaching 1.4K.

  • Jun 18, 2026

    Monthly visitors grew 52% MoM, from 716 to 1.1K.

Kamleon Filings

Explore SEC and related filing metadata, where available.

Kamleon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kamleon's valuation, stock price, and market status.

Is Kamleon a public or private company?

Kamleon is a private company.

What is the current stock price of Kamleon?

Kamleon is a private company with no public stock price. Caplight tracks Kamleon's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Kamleon worth (valuation)?

Valuation information for Kamleon is not publicly available.

Can I buy Kamleon stock?

Kamleon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kamleon's last funding round?

Kamleon's most recent funding round was Grant on August 20, 2025.

Who are the main investors in Kamleon?

Key investors in Kamleon include Spodeal Capital, ACCIÓ - Agency for Business Competitiveness, European Commission, Sportboost, European Union.

Will Kamleon IPO soon?

No public IPO plans have been announced for Kamleon.

How can I track Kamleon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kamleon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range14
Year Founded2017
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?